tiprankstipranks
Protagonist Therapeutics selects PN-881 as development candidate
PremiumThe FlyProtagonist Therapeutics selects PN-881 as development candidate
1M ago
Protagonist and JNJ say icotrokinra study for PsO meets endpoint
Premium
The Fly
Protagonist and JNJ say icotrokinra study for PsO meets endpoint
1M ago
Protagonist Therapeutics Reports Strong Financial Turnaround
Premium
Company Announcements
Protagonist Therapeutics Reports Strong Financial Turnaround
1M ago
Walmart upgraded, Starbucks downgraded: Wall Street’s top analyst calls
PremiumThe FlyWalmart upgraded, Starbucks downgraded: Wall Street’s top analyst calls
3M ago
Protagonist Therapeutics initiated with a Buy at TD Cowen
Premium
The Fly
Protagonist Therapeutics initiated with a Buy at TD Cowen
3M ago
Protagonist Therapeutics Board and Audit Committee Changes
Premium
Company Announcements
Protagonist Therapeutics Board and Audit Committee Changes
3M ago
Protagonist Therapeutics sees cash runway through end of 2027
PremiumThe FlyProtagonist Therapeutics sees cash runway through end of 2027
5M ago
Protagonist Therapeutics reports Q2 EPS (50c), consensus (60c)
Premium
The Fly
Protagonist Therapeutics reports Q2 EPS (50c), consensus (60c)
5M ago
Protagonist Therapeutics announces publication of clinical data on JNJ-2113
Premium
The Fly
Protagonist Therapeutics announces publication of clinical data on JNJ-2113
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100